Medizinische Universität Graz - Research portal
Schlenke Peter |
Presentations at scientific and public conferences
Alihodžić, D; Özkaya, E; Foßelteder, J; Sconocchia, T; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Wölfler, A; Vujić, N; Kratky, D; Reinisch, A
Investigating the contribution of TET2 mutant human clonal hematopoiesis to human atherosclerotic plaque formation in a novel LDLR/ApoE double knock-out mouse model.
Doctoral Day 2024; 08.02.2024; Graz, AUSTRIA. 2024.
[Poster]
Alihodžić, D; Özkaya, E; Foßelteder J; Sconocchia, T; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Wölfler A; Vujić, N; Kratky, D; Reinisch A
CRISPR/Cas9 genome engineering to model TET2 mutant human clonal hematopoiesis and its pro-atherogenic potential.
Austrian Atherosclerosis Society (AAS) Annual Meeting; MAI 2-4, 2024; St. Gilgen, AUSTRIA. 2024.
[Poster]
ALIHODŽIĆ, D; ÖZKAYA1, E; PABST, G; FOßELTEDER, J; SCONOCCHIA, T; AUINGER, L; SCHLENKE, P; SILL1, H; ZEBISCH, A; WÖLFLER, A; REINISCH, A
Modeling SRSF2/TET2 mutational cooperativity in CMML development
European Hematology Association (EHA) 2024 Hybrid Congress; JUNE 13-16, 2024; Madrid, SPAIN. 2024.
[Poster]
Foßelteder, J; Brauchart, T; Schlacher, A; Sconocchia, T; Özkaya, E; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Reinisch, A;
Engineered cytokine-expressing mesenchymal stromal cells support ex vivo culture of human HSPCs and AML cells.
BMS Future Talks; SEP 27-28, 2024; Vienna, AUSTRIA. 2024.
[Poster]
Herrmann, M; Zelzer, S; Cavalier, E; Kleber, M; Drexler-Helmberg, C; Schlenke, P; Curcic, P; Keppel, M; Enko, D; Scharnagl, H; Pilz, S; März, W
Personalized assessment of vitamin D status by a novel metabolic approach.
CLIN CHIM ACTA. 2024; 558: 118232--26th International Congress of Clinical Chemistry and Laboratory Medicine; MAY 26-30, 2024; Dubai, UNITED ARAB EMIRATES.
Doi: 10.1016/j.cca.2024.118232
[Poster]
Web of Science
FullText
FullText_MUG
Özkaya, E; Sconocchia, T; Foßelteder, J; Alihodzic, D;
Schlacher, A; Auinger, L; Schlenke, P; Sill, H; Zebisch, A; Reinisch, A
Genome engineered TET2 loss-of-function mutations increase stem cell self-renewal in human hematopoietic stem and progenitor cells.
Doctoral Day (DocDay); FEB 08 2024; Graz, Austria. 2024.
[Poster]
Avdili, A; Auer, M; Bernecker, C; Brislinger, D; Reinisch, A; Schlenke, P; Dorn, I.
Molecular characterization of emerging hematopoiesis from human iPSCs
DocDay 2023; FEB 9, 2023; Graz, AUSTRIA. 2023.
[Poster]
Avdili A, Auer M, Brislinger D, Matzhold EM, Bernecker C, Sundl M, Fuchs J, Schlenke P and Dorn I.
Characterization of emerging iPSC-derived hematopoiesis and erythropoiesis inside three-dimensional cellular complexes (hemanoids)
Gordon Research Conference Red Cells; June 4-9, 2023; Newport, Rhode Island, USA. 2023.
[Oral Communication]
Avdili A, Auer M, Brislinger D, Matzhold EM, Fuchs J, Bernecker C, Sundl M, Schlenke P and I. Dorn
iPSC-derived cultured red blood cells resemble fetal liver erythropoiesis
11th GSCN Conference; Sept 13-15, 2023; Ulm, Germany. 2023.
[Oral Communication]
Herrmann, M; Zelzer, S; Kleber, M; Drexler-Helmberg, C; Schlenke, P; Curcic, P; Enko, D; Scharnagl, H; Pilz, S; März, W
Increased all-cause mortality in individuals with functional vitamin D deficiency
Heft der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM). 2023; 61(S1):-XXV IFCC-EFLM EuroMedLab-WorldLab Congress 2023; May 21-25, 2023; Rom, ITALIEN;.
[Keynote lecture]
FullText
Rupp, J; Fessler, J; Hayer, S; Dreo, B; Lackner, A; Fasching, P; Helmberg, W; Schlenke, P; Thiel, J; Steiner, G; Weyand, CM; Stradner, M
Arthritogenic Cells Found in the Peripheral Blood of Rheumatoid Arthritis Patients Transfer the Disease to NSG-DR4 Mice
ARTHRITIS RHEUMATOL. 2023; 75: 4216-4216.
[Poster]
Web of Science
Zelzer, S; Kleber, M; Drexler-Helmberg, C; Schlenke, P; Curcic, P; Enko, D; Scharnagl, H; Pilz, S; März, W; Herrmann, M
Accelerated bone metabolism in individuals with functional vitamin D deficiency
Heft der Zeitschrift Clinical Chemistry and Laboratory Medicine (CCLM). 2023; 61(S1):-XXV IFCC-EFLM EuroMedLab-WorldLab Congress 2023; May 21-25, 2023; Rom, ITALIEN;.
[Poster]
FullText
Avdili, A; Auer, M; Bernecker, C; Reinisch, A; Schlenke, P; Dorn, I
GENERATION OF A CD43 FLUORESCENT REPORTER IPSC LINE TO TRACK HEMATOPOIETIC DEVELOPMENT
EXP HEMATOL. 2022; 111: S58-S58.
[Poster]
Web of Science
FullText
Avdili, A; Bernecker, C; Frisch, MT; Reinisch, A; Schlenke, P; Dorn, I.
Generation of a CD43 fluorescent reporter iPSC line to track hematopoietic development
24TH MEETING OF THE EUROPEAN RED CELL SOCIETY; April 7-11, 2022; Gazzado Schianno, Italy. 2022.
[Poster]
Avdili1, A; Bernecker, C; Reinisch, A; Schlenke, P; Dorn, I.
CRISPR/Cas9 mediated gene editing of human iPSC to track haematopoietic development
Sy-Stem Meeting 2022; APRIL 23-25, 2022; Vienna, Austria. 2022.
[Poster]
Curcic, P; Zelzer, S; Drexler, C; Niedrist, T; Meinitzer, A; Enko, D; Schlenke, P; Herrmann, M
Identification of functional vitamin D deficiency through the simultaneous measurement of 25(OH)D and 24,25(OH)2D by LC-MS/MS
Biochem Med (Zagreb). 2022; 32(Suppl1):S1-S235.-10th Congress of the Croatian Society of Medical Biochemistry and Laboratory Medicine with international participation; SEP 28 - OCT 2, 2022; Zagreb, CROATIA.
[Poster]
Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, I; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, B; Greinix, HT
Autologous stem cell transplantation as rescue
therapy for prolonged cytopenia after treatment
with CD19-targeted chimeric antigen receptor
modifed T-cells: two case reports
Frühjahrstagung 2022 der OeGHO; APR 8-10,2022; Graz. 2022.
[Poster]
FullText
Gaksch, L; Huber-Krassnitzer, B; Uhl, B; Bainschab, A; Sifferlinger, IA; Sill, H; Schlenke, P; Rosskopf, K; Beham-Schmid, C; Neumeister, P; Greinix, HT
Autologous stem cell boost for prolonged severe cytopenia after treatment with cd19-car-t-cells for refractory diffuse large b-cell lymphoma -two case reports
BONE MARROW TRANSPL. 2022; 57(SUPPL 1): 141-142.
[Poster]
Web of Science
FullText
Herrmann, M; Curcic, P; Drexler, C; Niedrist, T; Meinitzer, A; Enko, D; Schlenke, P; Zelzer, S
Identification of functional vitamin D deficiency through the simultaneous measurement of 25(OH)D and 24,25(OH)2D by LC-MS/MS
59th Australasian Association for Biochemistry and Laboratory Medicine (AACB) Annual Scientific Conference; OCT 18-20, 2022; Perth, AUSTRALIA. 2022.
[Oral Communication]
Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J
Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
ÖGR Jahrestagung 2022; NOV 3-5, 2022; Vienna, AUSTRIA. 2022.
[Poster]
Kahn, J; Matzhold, EM; Ofner-Kopeinig, P; Schlenke, P; Schemmer, P
Tailored immunosuppression with LCPT extended release Tacrolimus based on NFAT-regulated gene expression
Transplant International
Special Issue 31st Annual Meeting of the German Transplantation Society (DTG 2022). 2022; -Jahrestagung der deutschen Transplantationsgesellschaft; 29.09.2022-01.10.2022; Erlangen.
[Oral Communication]
Kahn, J; Matzhold, EM; Ofner-Kopeinig, P; Schlenke, P; Schemmer, P
Tailored Immunosuppression with LCPT extended relese Tacrolimus based on NFAT-regulated gene expression
Transplant International Special Issue Austrotransplant 2022. 2022; -Austrotransplant; OKT 19-21, 2022; Mayrhofen/Zillertal.
[Oral Communication]
Matzhold, EM; Körmöczi, G; Banfi, C; Schönbacher, M; Drexler-Helmberg, C; Steinmetz, I; Berghold, A; Schlenke, P; Wagner-Lichtenegger, G; Stoisser, A; Kleinhappl, B; Wagner, T
Reduced levels of ABO anti-A and anti-B of IGM, IGG and IGA isotypes in the serum but not the saliva of individuals recovered from COVID-19
Vox Sanguinis. 2022;117(Suppl. 1):6–271.
ISBT 2022 Abstract Book
DOI: 10.1111/vox.13285. 2022; -ISBT 2022 ; JUNE 4-8, 2022; Virtual.
[Oral Communication]
Niedrist, T; Drexler, C; Torreiter, PP; Matejka, J; Strahlhofer-Augsten, M; Kral, S; Riegler, S; Gülly, C.; Krause, R; Berghold, A; Steinmetz, I; Schlenke, P; Herrmann, M
Comparison of SARS-CoV-2 antibody assays aligned to the WHO standard NIBSC 20/136
EuroMedLab Munich 2021: Abstracts Issue. 2022; 59(s1):637-757.-EUROMEDLAB 2021; APR 10-14, 2022; Munich, GERMANY.
[Poster]
FullText
Pabst, G; Foßelteder, F; Schlacher, A; Auinger, L; Martinez-Krams, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, Ch; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A;
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells.
Blood (2021) 138 (Supplement 1): 2160.. 2022; 138: 2160-2160.-ASH Annual Meeting 2021; DEZ 11-14, 2021; Atlanta, USA.
[Poster]
FullText
Rudzki, JD; Jaeger, U; Wolf, D; Petzer, A; Greil, R; Peters, C; Greinix, HT; Attarbaschi, A; Buxhofer-Ausch, V; Girschikofsky, M; Holter, W; Leisch, M; Neumeister, P; Schlenke, P; Schmitt, CA; Schwinger, W; Worel, N; Wohlfarth, P
Stringent Nationwide Selection Criteria for CAR-T Cell Therapy Ensure Favourable Outcome of Patients with LBCL - First Data from the Austrian CAR-T Network
BLOOD. 2022; 140: 6661-6663.-64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 10-13, 2022; New Orleans, LA.
Doi: 10.1182/blood-2022-167603
[Poster]
Web of Science
FullText
FullText_MUG
Rupp, J; Fessler, J; Hayer, S; Dreo, B; Lackner, A; Fasching, P; Helberg, W; Schlenke, P; Thiel, J; Steiner, G; Cornelia, W; Stradner, M
TRANSFER OF HUMAN RHEUMATOID ARTHRITIS MONONUCLEAR CELLS INDUCES ARTHRITIS IN IMMUNODEFICIENT HLA-DR4 TRANSGENIC MICE
ANN RHEUM DIS. Abstracts of the EULAR 2022 European Congress of Rheumatology. 2022; 81: 460-460.-EULAR 2022 European Congress of Rheumatology; JUN 1-4, 2022; Copenhagen, DENMARK.
Doi: 10.1136/annrheumdis-2022-eular.367
[Poster]
Web of Science
FullText
FullText_MUG
Sourij, C; Aziz, F; Kojzar, H; Obermayer, A; Sternad, C; Forstner, P; Muller, A; Tripolt, N; Pferschy, P; Aberer, F; Schlenke, P; Kleinhappl, B; Stradner, M; Sareban, N; Moritz, M; Dominguez-Villar, M; Oliver, N; Sourij, H
SARS-CoV-2S antibody formation is not impaired in people with type 1 or type 2 diabetes, but the antibody level falls more rapidly in this collective - the -COVAC-DM study
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):259-260.
[Oral Communication]
Web of Science
Ulrich, S; Lang, J; Posch, U; Schlenke, P
Identification of the novel HLAC*03:03:01:52N allele and confirmation of HLAC*03:03:01:50, renamed HLA-C*03:03:01:50N
HLA. 2022; 99(5): 541-541.
[Poster]
Web of Science
Zwittnig, K; Kirnbauer, B; Jakse, N; Schlenke, P; Mischak, I; Ghanaati, S; Al-Maawi, S; Végh, D; Zrnc , TA; Payer M
Liquid versus solid Platelet-rich fibrin (PRF)-
Differences in growth factor release
-. 2022; -EAO Congress 2022; SEP 29- OCT 1, 2022; Geneva, SWITZERLAND.
[Poster]
Bernecker, C; Leita, R; Kolesnik, T; Lampl, A; Ciubotaru, CD; Fröhlich, E; Schlenke, P; Cojoc, D; Dorn, I
Comprehensive analyses of the link between shape, structure and function in ex vivo generated and native red blood cells
ISEH 50th annual scientific meeting; AUG 26-29, 2021; New York, USA. 2021.
[Onlinepräsentation]
FullText
Foßelteder, J; Schlacher, A; Pabst, G; Amtmann, B; Schöll, W; Kashofer, K; Beham-Schmid, C; Schlenke, P; Greinix, HT; Sill, H; Woelfler, A; Zebisch, A; Reinisch, A
Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN Pathogenesis
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-147919
[Poster]
Web of Science
FullText
FullText_MUG
Krizanic, KK; Rosskopf, K; Payrat, JM; Andresen, S; Pruller, F; Schlenke, P
Stability of Cryoprecipitate from Pathogen Reduced Apheresis Plasma: 2-year Frozen Storage Post-production and 120 Hours Storage at Room Temperature
TRANSFUSION. 2021; 61: 72A-72A.
[Keynote lecture]
Web of Science
Pabst, G; Foßelteder, J; Schlacher, A; Auinger, L; Martinez-Krams3, D; Ediriwickrema, A; Kashofer, K; Beham-Schmid, C; Greinix, HT; Woelfler, A; Schlenke, P; Sill, H; Zebisch, A; Majeti, R; Reinisch, A
Modeling the Development of SRSF2 Mutated Myeloid Malignancies By CRISPR/Cas9 Mediated Genome Engineering of Primary Human Hematopoietic Stem and Progenitor Cells
Blood. 2021; 138(S1):-Annual Meeting of the American Society of Hematology (ASH); DEC 11-14, 2021; Atlanta, USA.
Doi: 10.1182/blood-2021-149591
[Poster]
Web of Science
FullText
FullText_MUG
Tripolt, N; Sourij, C; Aberer, F; Kojzar, H; Obermayer, A; Pferschy, P; Aziz, F; Muller, A; Abbas, F; Lenz, J; Mader, J; Pesto, L; Banfic, T; Leitner, M; Steinberger, M; Knoll, L; Goswami, N; Moser, O; Eckstein, M; Wachsmuth, N; Cvirn, G; Stradner, M; Schlenke, P; Kaser, S; Steinmetz, I; Sourij, H
Immune Response to COVID-19 Vaccination for Patients with Diabetes mellitus - The Covac-DM Austria Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):228-228.
[Oral Communication]
Web of Science
Wimmer, M; Lackner, S; Hodl, I; Fessler, J; Schlenke, P; Moritz, M; Sareban, N; Stradner, M; Holasek, SJ
Differences in Dietary Quality and Inflammation Index in Immunocompromised and
Healthy Individuals - Preliminary Results.
Ernährung aktuell. 2021; (4):24-24.-ÖGE-Jahrestagung; NOV 24-26, 2021; Vienna, AUSTRIA.
[Poster]
Avdili, A; Bernecker, C; Frisch, MT, Reinisch, A; Schlenke, P; Dorn, I.
Generation of a CD43 fluorescent reporter cell line using CRISPR/Cas9 gene editing to track hematopoietic development from human iPSCs
8th annual GSCN Conference; SEPT 23-25, 2020; Ulm, Germany. 2020.
[Poster]
FullText
Bernecker, C; Lima, M; Ciubotaru, CD; Frisch, MT; Lampl, A; Rohrhofer, L; Schlenke, P; Dorn, I; Cojoc, D
Biomechanical properties of ex vivo cultured and native red blood cells –New approaches with Optical Tweezers and Digital Holographic Microscopy.
Pavia online meeting - The Horizons in Red Cell Research. 2020; -European Red Cell Society (ERCS2020); SEP 11, 2020; Pavia, ITALY.
[Oral Communication]
Kovacic Krizanic, K; Rosskopf, K; Andresen, S; Payrat, JM; Prüller, F; Torreiter, P; Fuchs, T; Url, C; Schlenke, P
Production of cryoprecipitate from pathogen reduced apheresis plasma and post-thawing quality after 120 hours at ambient temperature.
Vox Sanguinis
P-293
. 2020; Volume 115(S1):-ISBT 2020; DEC 12-16, 2020; virtual.
[Poster]
Matzhold, EM; Berghold, A; Kessler, H; Stelzl, E; Steinmetz, I; Krause, R; Wurzer, H; Bemelmans, M; Stoisser, A; Schlenke, P; Wagner, T
THE ROLE OF ABO AND LEWIS TISSUE ANTIGENS AND SECRETOR STATUS AS RISK FACTORS FOR THE INFECTION WITH SARS-COV-2 AND CLINICAL OUTCOME OF COVID-19 DISEASE.
https://doi.org/10.1111/vox.13031
Vox Sanguinis, Special Issue: The 36th International ISBT Congress, Virtual meeting, 12–16 December 2020, December 2020. 2020; 115(S1):-ISBT 2020 - Virtual; Dec 12-16, 2020; Virtual, Netherlands.
[Onlinepräsentation]
FullText
Matzhold, E.M.
Berghold, A
Kessler, H
Steinmetz, I
Stelzl, E
Krause, R
Wurzer, H
Schlenke, P
Simonic, K.-M
Bemelmans, M
Stoisser, A
Wagner, T
Association of ABO and Lewis tissue antigens and secretor status with the infection of SARSCoV-2 and severity of COVID-19 disease: a retrospective study.
Transfus Med Hemother 2020;47(suppl 1):1–74
PL 3-5. 2020; -53. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e. V., DGTI2020; Sep 16-18, 2020; Jena, Deutschland.
[Onlinepräsentation]
FullText
Rosskopf, K; Helmberg, W; Schlenke, P
Economic Aspects of Pathogen Reduction od Double Dose Platelet Concentrates from Pools of Eight Buffy Coats.
ISBT 2020; DEC 12-16, 2020; virtual. 2020.
[Poster]
T. Wagner, K. Stöger, C. Jungbauer, P. Schlenke
Paradigm shift in traditional blood donation: no doctor on site – legal requirements and medical consequences.
Transfusion Medicine and Hemotherapy. 2020; 47(S1):10-10.-53. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI); Sept 16-18, 2020; Berlin, Germany. (ISBN: 978-3-318-06716-3 )
[Oral Communication]
Bernecker, C; Köfeler, H; Trajanoski, S; Trötzmüller, M; Pabst, G; Rohrhofer, L; Strohmayer, K; Holzapfel, G; Schlenke, P; Dorn, I
High resolution mass spectrometry analyses of the membrane lipid composition of ex vivo cultured and native red blood cells
22nd ERCS Meeting "Red Cell research on the Mount of Truth"; MÄR 8-12, 2019; Ascona, SWITZERLAND. 2019.
[Poster]
C. Bernecker, H. Köfeler, S. Trajanoski, M. Trötzmüller, G.Pabst, L. Rohrhofer, K. Strohmayer, G. Holzapfel, P. Schlenke and I. Dorn
Membrane lipid composition of ex vivo cultured and native red blood cells measured by high resolution mass spectrometry
Gordon Research Conference Red Cells; JUL 13-19; Rhode Island, USA. 2019.
[Poster]
Foßelteder, J; Wölfler, A; Kargl, J; Schöll, W; Schlenke, P; Sill, H; Reinisch, A
In-vitro modeling of JAK2 V617F-driven myeloproliferative neoplasms
using CRISPR/Cas9 genome engineering.
DocDay 2019, Medical University of Graz; 21.11.2019; Graz, AUSTRIA. 2019.
[Poster]
Kovacic, K; Rosskopf, K; Andresen, S; Payrat, JM; Prüller, F; Torreiter, P; Fuchs, T; Url, C; Schlenke, P;
Production of Cryoprecipitate from a jumbo pool of two apheresis plasma units pathogen-inactivated with INTERCEPT(TM) Blood System
Transfusion Medicine and Hemotherapy. 2019. 2019; -52. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI); Sept 18-20, 2019; Mannheim, GERMANY.
[Poster]
Mosinzer, S; Foßelteder, J; Avdili, A; Schlenke, P; Reinisch, A
Generation of a TP53 isogenic cell line using CRISPR/Cas9 genome engineering
DocDay 2019, Medical University of Graz; Nov 21, 2019; Graz, AUSTRIA. 2019.
[Poster]
Torreiter, P; Kovacic, K; Matzhold, E; Macher, S; Schlenke, P; Wagner, T;
Course of anti-Rh17 (Anti-Hr0)-titer during pregnancy of a multipara with rare –D–/–D– phenotype
Transfusion Medicine and Hemotherapy. 2019. 2019; -52. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI); Sept 18-20, 2019; Mannheim GERMANY.
[Poster]
Bernecker, C; Ackermann, M; Lachmann, N; Zaehres, H; Schlenke, P; Dorn, I
A simplified Model for ex vivo erythropoiesis from hiPSCs
XXX. 2018; -ESH 2nd International Symposium on Red Blood Cells: Genesis and Pathophysiology ; APR 18-20, 2018; Paris, FRANCE.
[Poster]
Bernecker, C; Lachmann, N; Ackermann, M; Zaehres, H; Schlenke, P; Dorn I
Enhanced erythroid differentiation from human iPSCs with minimal cytokine Support.
Transf Med Hemotherapy
. 2018; 45(S1):1-90.-51. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V. (DGTI); SEP 19-21; Lübeck.
[Oral Communication]
FullText
Eva M. Matzhold, Claudia Bernecker, Peter Schlenke, Isabel Dorn
Gene expression during human erythropoiesis analyzed by droplet digital PCR using different panels of reference genes
ESH Paris. 2018; -2nd International Symposium on Red Blood Cells: Genesis and Pathophysiology; April 18-20, 2018; Paris, France.
[Poster]
Lichtenegger S., Stiehler J., Zauner A., Bernecker C., Schlenke P., Kleinhappl B., and Steinmetz I.
Innate immune mechanisms against intracellular bacterial pathogens
1st Scientific Retreat of the Diagnostic and Research Center for Molecular BioMedicine on Genetic and Environmental Mechanisms of Disease ; Okt 31 - Sept 01; Graz. 2018.
[Oral Communication]
Lichtenegger, S; Stiehler, J; Zauner, A; Bernecker, C; Schlenke, P; Steinmetz, I
Establishment of a standardized primary human macrophage-based
infection model for B. pseudomallei
European Melioidosis Congress; MAR 19-21, 2018; Oxford, UK. 2018.
[Oral Communication]
Rosskopf, K; Helmberg, W; Schlenke, P
Bewertung des Einflusses der Pathogeninaktivierung von Thrombozytenkonzentraten auf die Qualität, den Herstellungsprozess und die Kosten nach zwei Jahren im Routineinsatz
51. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V. (DGTI); 19-21 SEPT, 2018; Lübeck. 2018.
[Oral Communication]
Rosskopf, K; Sipurzynski, S; Posch, U; Schwinger, W; Torreiter, P; Kovacic, K; Schlenke, P
RED BLOOD CELL DEPLETION OF BONE MARROW: COMPARISON OF TWO CELL SEPARATORS AND FIRST EXPERIENCE WITH SMALL VOLUME GRAFTS
TRANSPL INT. 2018; 31: 20-20.
[Oral Communication]
Web of Science
Schlenke, P
Gesteigerte erythrozytäre Differenzierung aus humanen iPS Zellen unter minimaler Zytokingabe.
51. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V. (DGTI); 19-21 SEPT, 2018; Lübeck. 2018.
[Oral Communication]
Schlenke, P
Der Einfuss der Pathogeninaktivierung von Thrombozytenkonzentraten nach 2 Jahren Routineanwendung, auf die Qualität, den Herstellprozess sowie die Wirtschaftlichkeit.
51. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V. (DGTI); 19-21 SEPT, 2018; Lübeck. 2018.
[Oral Communication]
Schlenke, P
Pathogeninaktivierung von Blutkomponenten: Update 2018.
51. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie e.V. (DGTI); 19-21 SEPT, 2018; Lübeck. 2018.
[Oral Communication]
Bernecker, C; Dorn, I; Lachmann, N; Ackermann, M; Zaehres, H; Schlenke, P
Enhanced ex vivo erythropoiesis from hiPSCs
by a simplified culture System.
Experimental Hematology
. 2017; 53(S1):S1-S148.-ISEH 46th Annual Scientific Meeting; AUG 24-27, 2017; Frankfurt, Germany.
[Poster]
FullText
Dorn I, Bernecker C, Lachmann N, Ackermann M, Zaehres H, Schlenke P.
Enhanced ex vivo erythropoiesis from hiPSCs by a simplified culture System.
Gordon Research Conference, Gordon Research Seminar; Rhode Island, Jul 2017; USA. 2017.
[Poster]
Dorn I, Bernecker C, Trajanoski S, Zaehres H, Schlenke P, Wagner W.
DNA methylation of manufactured red blood cells from human induced pluripotent stem cells
Experimental Hematology. 2017; 53(S1):-46th Annual Scientific Meeting of the International Society of Experimental Hematology; Aug 24-27, 2017; Frankfurt, GERMANY.
[Poster]
FullText
Isabel Dorn, Claudia Bernecker, Slave Trajanoski, Holm Zaehres, Wolfgang Wagner, and Peter Schlenke
Human iPSC‐ and hematopoietic stem cell‐derived erythroid precursors differ in their DNA methylation profile
Online Abstractband. 2017; -5th Annual Conference of the German Stem Cell Network (GSCN)
; Sep 11-13, 2017; Jena, Germany.
[Poster]
FullText
Macher, S; Drexler, C; Lindenau, I; Sipurzynski, S; Stojakovic, T; Holter, M; Moritz, M; Schlenke, P; Amrein, K
High-dose intravenous iron versus oral iron in blood donors with iron deficiency: The Ironwoman randomised, controlled Trial.
Vox Sanguinis. 2017; 112(S1):113-114.-27th regional Congress of the ISBT; JUN 17 - 21, 2017; Copenhagen, Danmark.
[Poster]
Rosskopf, K; Helmberg, W; Fuchs, T; Schlenke, P
Pathogen inactivation of double platelet concentrates made of eight buffy coats: to kill two birds with one Stone.
Vox Sanguinis. 2017; 112(S1):-27th regional Congress of the ISBT; JUN 17 - 21, 2017; Copenhagen, Danmark.
[Poster]
Ulrich, S; Matzhold, EM; Posch, U; Schlenke, P; Helmberg, WM
IDENTIFICATION OF A NOVEL HLA-DRB3 ALLELE
HLA. .. 2017; 89(6):471-471.
[Poster]
Web of Science
Amrein, K; Drexler, C; Macher, S; Schlenke, P; Schrock, M
Perceptions and management of iron deficiency in blood donors among general practitioners and internists
WIEN KLIN WOCHENSCHR. 2016; 128: S379-S379.-ÖGIM Jahrestagung; SEP; Salzburg, AUSTRIA.
[Poster]
Web of Science
Katharina Kessel, Christian Bartenhagen, Claudia Bernecker, Martina Sinn, Lisa
Rohrhofer, Ingrid Gelker, Hans Schöler, Holm , Peter Schlenke, and Isabel Dorn
Transcriptional profiling of in vitro generated red blood cells from human adult HSCs and pluripotent stem cells
Abstract No. P046, online Webpublication
. 2016; -4th Annual Conference of the German Stem Cell Network (GSCN)
; Sep 12 – 14, 2016; Hannover, Germany.
[Poster]
FullText
Kessel K, Bartenhagen C, Bernecker C, Sinn M, Rohrhofer L, Gelker I, Schöler H, Zaehres H, Schlenke P, Dorn I
Transcriptional profiling of in vitro generated red blood cells from human adult HSCs and pluripotent stem cells
http://www.gscn.org/Portals/0/Conferences/2016/Documents/Programmheft_GSCN_2016_short_web.pdf?ver=2016-09-02-191401-727. 2016; -4th Annual Conference of the German Stem Cell Network (GSCN); Sep 12-14, 2016; Hannover, Germany.
[Poster]
FullText
Kessel, K; Barthagen, C; Bernecker, C; Zaehres, H; Schöler, H; Schlenke, P; Dorn, I
Transcriptional profiling of in vitro generated human red blood cells from human HSCs and pluripotent stem cells
4th International Annual Conference 2016 of the German Stem Cell Network (GSCN); 12.-14. September 2016; Hannover. 2016.
[Poster]
Macher, S; Zinke-Cerwenka, W; Posch, U; Ulrich, S; Sipurzynski, S; Greinix, H; Schlenke, P
Thrombozytenrefraktärität durch Anti-HPA 3a bei Zustand nach allogener Blutstammzelltransplantation: ein Fallbericht.
TRANSPL INT. . 2016; 29(s4):21-21.-Austrostransplant 2016; OCT 19-21, 2016; Schladming, AUSTRIA.
[Poster]
Web of Science
Rosskopf, K; Helmberg, W; Fuchs, T; Sommer, M; Url, C; Vasic, B; Andresen, S; Bauhaus, M; Moerman, N; Schlenke, P
Pathogen inactivation of double platelet concentrates made of eight buffy coats: results from a validation study.
Transfusion Medicine and Hemotherapy. 2016; 43(S1):-DGTI; 07.-10.09..2016; Nürnberg.
[Oral Communication]
Schlenke, P
Stammzellbasierte Regeneration von Blut und Gewebe
Stammzelltag 2016; JUN 6, 2016; Wien. 2016.
[Keynote lecture]
Schlenke, P
The Vision of Artificial Blood Supply.
IAB Satellite Symposium: Socio-Ethical and Legal (ELSI) Implications of Genome Editing Technologies ; JUN 14, 2016; Edinburgh. 2016.
[Oral Communication]
Schlenke, P
Qualität und Sicherheit in der Blutherstellung.
Gedanken- und Informationsaustausch zum Thema Patient Blood Management; 14. Juli 2016; Graz. 2016.
[Oral Communication]
Schröck, M; Drexler, C; Moritz, M; Schlenke, P; Amrein, K; Macher, S
Iron deficiency: perceptions and management among physicians in Styria.
Transfusion Medicine and Hemotherapy. 2016; 43(S1):-DGTI; 07.-10.09..2016; Nürnberg.
[Poster]
Ulrich, S; Posch, U; Helmberg, W; Schlenke, P
A NOVEL HLA -A ALLELE: HLA A-A*68:02:11
HLA. 2016; 87(4):291-291.
[Poster]
Web of Science
Dorn, Isabel, Klich, Katharina, Bluemke, Anika, Mavrommatis,
Lampros, Arauzo-Bravo, Marcos J., Schwinger, Wolfgang, Urban,
Christian, Schöler, Hans R, Schlenke, Peter, Zaehres, Holm
TARGETING HEMOGLOBIN EXPRESSION IN ERYTHROCYTES
FROM SICKLE-CELL DISEASE PATIENT-DERIVED INDUCED
PLURIPOTENT STEM CELLS
http://www.isscr.org/docs/default-source/2015-am-stockholm/isscr-2015-abstract-book.pdf?sfvrsn=2
Abstract F-1317. 2015; -Annual Meeting of the ISSCR 2015 ; Jun 24-27, 2015; Stockholm, Sweden.
[Poster]
FullText
Drexler C, Macher S, Schlenke P, Lindenau I
Eisenintervention bei BlutspenderInnen
Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie; 09, 2015; 2015.
[Oral Communication]
Drexler, C; Macher, S; Stojakovic, T; Sipurzynski, S; Reinprecht, C; Lindenau, I; Schröck, M; Sareban, N; Schlenke, P; Amrein, K
Preliminary results of the IronWoMan study: a randomized, controlled trial about high dose intravenous iron supplementation for blood donors with iron deficiency
Transfusion Medicine and Hemotherapy. 2015; 42(S1):16-16.-48. Jahreskongress der DGTI; SEPT 15-18,2015; Basel, Schweiz.
[Oral Communication]
Macher, S; Drexler, C; Stojakovic, T; Schröck, M; Reinprecht, C; Lindenau, I; Sareban, N; Schlenke, P; Amrein, K
Intravenous vs oral iron supplementation for blood donors with iron deficiency.
Vox Sanguinis. 2015; 109(S1):58-58.-25.th Regional Congress of the ISBT; JUN 27- JUL 1, 2015; London, UK.
[Oral Communication]
Macher, S; Wagner, T; Rosskopf, K; Reiterer, F; Csapo, B; Schlenke, P; Klaritsch, P
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasis.
VOX SANGUINIS. 2015; 109(S1):319-319.-25.th Regional Congress of the ISBT; JUN 27- JUL 1, 2015; London, UK.
[Poster]
Rohban, R; Etchart, N; Schlenke, P; Heinemann, A; Holzer, P; Strunk, D; Szoke, K; Brinchmann, JE; Pieber, TR
Human endothelial colony forming cell transplantation into NSG mice leads to micro-vessel generation without co-transplanted human mesenchymal stromal cells.
The NYSCF Research Institute Ninth Annual Translational Stem Cell Research Conference; OCT 22-23, 2014; New York, USA. 2014.
[Poster]
Schlenke, P
Aktualisierung der "Gemeinsamen Stellungnahme der Fachgesellschaften DGTI, DGHO und GPOH zu Genehmigungsverfahren von Stammzellzubereitungen"
Meeting Paul-Ehrlich-Institut; MAY 13-14, 2014; Frankfurt/Langen. 2014.
[Oral Communication]
Schlenke, P;
Lassen sich die immunologischen Barrieren in der Spenderauswahl überwinden?
Stem Cell Therapy meets Solid Organ Transplantation; SEPT 27, 2014; Graz, AUSTRIA. 2014.
[Oral Communication]
Schlenke, P;
"Patient Blood Management“ ein theoretisches Konzept und seine klinische Umsetzung
Arbeitskreis Hämotherapie und internes Symposium zum Thema PBM; SEPT 18, 2014; Mannheim, GERMANY. 2014.
[Oral Communication]
Bornhauser, M; Lenk, J; Kramer, M; Poppe-Thiede, K; Schmidt, H; Kristina, H; Wiesneth, M; Schafer-Eckhart, K; Schlenke, P; Punzel, M; Martin, S; Kroschinsky, F; Schmidt, A; Ehninger, G; Thiede, C
Efficacy of G-CSF mobilization is not associated with the CXCL12 801 G/A-polymorphism: a study in 463 healthy volunteer donors
BONE MARROW TRANSPL. .. 2013; 48: S105-S106.-39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT); APR 07-10, 2013; London, ENGLAND.
[Poster]
Web of Science
Dorn, I; Klich, K; Radstaak, M; Psathaki, K; Arauzo-Bravo, M; Burr, B; Kim, JB; Kramer, J; Scholer, H; Zaehres, H; Schlenke, P
RED BLOOD CELL GENERATION FROM HUMAN INDUCED PLURIPOTENT STEM CELLS OF DIFFERENT DONOR CELL TYPE ORIGIN
EXP HEMATOL. .. 2013; 41(8):S27-S27.-42nd Annual Scientific Meeting of the International-Society-for-Experimental-Hematology-and-Stem-Cells (ISEH); AUG 22-25, 2013; Vienna, AUSTRIA.
Doi: 10.1016/j.exphem.2013.05.110
[Poster]
Web of Science
FullText
FullText_MUG
Dorn I, Klich K, Radstaak M, Psathaki K, Arauzo-Bravo M, Burr B, Kim JB, Kramer J, Schöler H, Zaehres H, Schlenke P.
Red blood cell generation from human induced pluripotent stem cells of different donor cell typ origin.
Exp Hematol 2013
. 2013; 41(8, S1):27--42nd Annual Scientific Meeting of the International Society of Experimental Hematology (ISEH)
; Aug 22-25, 2013; Wien.
[Poster]
Dorn I, Schlenke P, Radstaak M, Klich K, Psathaki K, Arauzo-Bravo MJ, Santourlidis S, Kögler G, Wernet P, Burr B, Kim JB, Kramer J, Schoeler HR, Zaehres H.
Erythrocyte induction from human induced pluripotent stem cells
independent of somatic cell origin
Gordon Research Conference / Gordon Reserach Seminar; Jul 6-12; 2013; New Hampshire; USA. 2013.
[Poster]
Isabel Dorn, Peter Schlenke, Martina Radstaak, Katharina Klich, Marcos J. Arauzo-Bravo, Simon Santourlidis, Boris Burr, Jeong Beom Kim, Hans R. Schöler, Holm Zaehres
Erythrocyte induction from human induced pluripotent stem cells independent of somatic cell origin.
Online Abstract W-2186. 2013; -11th Annual Meeting ISSCR; Jun 12-15, 2013; Boston, USA.
[Poster]
FullText
Isabel Dorn1,2, Peter Schlenke3, Martina Radstaa k1, Katharina Klich1,3, Katherina Psathaki1,
Marcos J. Arauzo-Bravo1, Simon Santourlidis4, Gesine Kögler4, Peter Wernet4, Boris Burr1,
Jeong Beom Kim5, Jan Kramer6, Hans R. Schöler1, Holm Zaehres1
Erythrocyte induction from human induced pluripotent stem cells
independent of somatic cell origin
Gordon Research Conference und Gordon Research Seminar; Jul 2013; New Hampshire, USA. 2013.
[Poster]
Katharina Klich, Peter Schlenke, Martina Radstaak, Katherina Psathaki, Marcos J. Arauzo-Bravo, Boris Burr, Jan
Kramer, Hans R. Schöler, Holm Zaehres, Isabel Dorn
Red blood cell generation from human induced pluripotent stem cells
Abstract 38, page 65. 2013; -7th International Meeting
Stem Cell Network North Rhine-Westphalia; April 23-24, 2013; Cologne, Germany.
[Poster]
FullText
Klich K, Schlenke P, Radstaak M, Psathaki K, Arauzo-Bravo M, Burr B, Kim JB, Kramer J, Schöler HR, Zaehres H, Dorn I.
Red blood cell generation from human induced pluripotent stem cells.
Abstract 38. 2013; -7th International Meeting of the Stem Cell Network NRW; Apr 23-24, 2013; Köln, Germany.
[Poster]
FullText
Dorn I, Schlenke P, Radstaak M, Schoeler HR, Zaehres H.
Erythropoiesis from human embryonic and induced pluripotent stem cells.
Abstractband Kompetenznetzwerk NRW, Interne Klausurtagung Herne 4.-5. Mai 2012. 2012; -Kompetenznetzwerk Stammzellforschung NRW Mai 2012 (Vortrag); Mai 4-5, 2012; Herne, Germany.
[Oral Communication]
Dorn, I; Schlenke, P; Radstaak, M; Sibrowski, W; Scholer, HR; Zaehres, H
Ex vivo generation of erythroid cells from human induced pluripotent stem cells of different origin
BONE MARROW TRANSPL. 2012; 47: S49-S49.-38th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT); APR 01-04, 2012; Geneva, SWITZERLAND.
[Oral Communication]
Web of Science
Humpe, A; Schill, S; Schlenke, P; Rossig, C; Stelljes, M; Silling, G; Schrauder, A; Buwitt-Beckmann, U; Gramatzki, M
Retrospective analysis of bone marrow grafts: comparison of unmanipulated bone marrow grafts with manipulated bone marrow grafts due to AB0 blood group incompatibility between donor and recipient
BONE MARROW TRANSPL. 2012; 47: S233-S233.
Web of Science
Dorn I, Schlenke P, Bleidissel M, Sibrowski W, Schöler HR, Zaehres H.
Ex vivo generation of red blood cells from human pluripotent stem cells.
Transfusion Medicine and Hemotherapy. 2011; 38(S1):18--44th Annual Congress o the German Society for Transfusion Medicine and Immunohematology (DGTI); Sep 27-30, 2011; Hannover, Germany.
[Oral Communication]
Dorn I, Haertel C, Gutsche S, Lazar-Karsten P, driller B, Schlenke P, Bucsky P.
Prolonged Anemia in an Intrauterine Transfused Neonate with Rh-Haemolytic Disease: No Impact of Anti-Rh(D) Antibodies on In-virto-Erythropoiesis.
Transf Med Hemother 2008
. 2008; 35(S1):28--Jahreskongress der DGTI; 2008; Düsseldorf, Germany.
[Oral Communication]
Dorn I, Meyer G, Lazar-Karsten P, Driller B, Schlenke P.
Influence of mesenchymal Stem Cells on human In-vitro Erythropoiesis.
Transf Med Hemother 2008. 2008; 35(S1):31--31. Jahreskongress der DGTI; Sep 16-19, 2008; Düsseldorf, Germany.
[Oral Communication]
Dorn I, Boie S, Hartwig D, Langenstrassen P, Luhm J, Schlenke P.
The influence of ADAR1 in Human Hematopoiesis and Erythroid Differentiation.
Transf Med Hemother 2007. 2007; 34(S1):11--11. Jahreskongress der DGTI; Sep 18-21, 2007; Friedrichshafen, Germany.
[Oral Communication]
Dorn I, Boie S, Schlenke P, Luhm J, Kirchner H, Hartwig D. ISEH 2007, Hamburg, Germany.
The role of ADAR1 in human hematopoiesis.
Exp Hematol. 2007; 35: -36th Annual Scientific Meeting of the ISEH-Society for Hematology and Stem Cells, ISEH 2007; Sep 28-30, 2007; Hamburg, Germany.
[Poster]
Lazar-Karsten, P; Dorn, I; Driller, B; Schlenke, P
Transcriptional profiling of in vitro erythroid progenitors.
J Stem Cells Regen Med. 2007; 2(1): 131-131.
PubMed
Lazar-Karsten P, Dorn I, Driller B, Schlenke P
Transcriptional profiling of in vitro erythroid progenitors
JSRM. 2007; 2(1):131--2nd Congress of the German Society for Stem Cell Research; Oct 4-6, 2007; Würzburg, GERMANY.
[Poster]
FullText
Meyer, G; Lazar-Karsten, P; Lindner, U; Driller, B; Dorn, I; Schlenke, P
Co-culturing of in vitro erythropoiesis with extra cellular matrix proteins
JSRM . 2007; 2(1):136--2nd Congress of the German Society of Stem Cell Research; oct 4-6, 2007; Würzburg, GERMANY.
[Poster]
PubMed
FullText
I. Dorn, J. Ribbat, P. Lazar, S. Boie, H. Kirchner, P. Schlenke.
In vitro erythropoiesis induced from CD34+ stem cells is influenced by the oxýgen content.
Vox sanguinis 2006. 2006; 91(S3):31--XXIXth International Congress of the ISBT 2006; Sep 2-7, 2006; Cape Twon, South Africa.
[Oral Communication]
I Dorn, J. Ribbat, S. Boie, P. Lazar, B. Driller, H. Kirchner, P. Schlenke.
In vitro generation of human red blood cells under different culture conditions.
Abstract O264. 2006; 37(S1):-32nd Annual Meeting of the EBMT; Mar 19-22, 2006; Hamburg, Germany.
[Oral Communication]
I. Dorn, P. Lazar, J. Luhm, P. Koritke, S. Malchow, H. Kirchner, P. Schlenke.
TNFalpha and its receptors are differentially expressed during in vitro erythropoiesis
Exp Hematol. 2006
. 2006; 34(9S1):35-86.-35th Annual Scientific Meeting of the International Society for Experimental Hematology (ISEH); Sep 27-30 ; Minneapolis, USA.
[Poster]
I. Dorn, P. Lazar, S. Boie, S. Malchow, P. Langenstrassen, H, Kirchner, J. Luhm, P. Schlenke.
Erythroid progenitors express TNFa and ist receptors in vitro.
Transf Med Hemother 2006;33(suppl 1):37. . 2006; 33(S1):37--39. Jahreskongress der DGTI ; Sep 19-22, 2006; Frankfurt, Germany.
[Poster]
I.Dorn, J.Ribbat, S.Boie, B.Driller, H.Kirchner, P.Schlenke
In vitro generation of human red blood cells
Annals of Hematology
. 2006; 85(9):641-646.-7th International Lübeck Conference on the Pathophysiology and Pharmacology of Erythropoietin and other Hemopoietic Growth Factors; Sep 6-9, 2006; Lübeck, Germany.
[Poster]
D. Hartwig I. Dorn, H. Kirhcner, P. Schkenke.
Recommendations for optimized settings of the Amicus Crescendo cell separator for the collection of CD34+ progenitor cells.
Transf Med Hemother 2005. 2005; 32(S1):-38. Jahreskongress der DGTI ; 2005; Erfurt, Germany.
[Poster]
Dorn I, Ribbat J, Hartwig D, Boie SA, Schlenke P.
In vitro proliferation and differentiation of human CD34 positive stem cells to reticulocytes.
Transfusion 2005. 2005; 45(3S):25A--Annual Meeting of the AABB 2005 Seattle, USA (Vortrag).; Oct 15-18, 2005; Seattle, USA.
[Oral Communication]
Dorn I, Ribbat S, Bioe S, Hartwig D, Driller B, Schlenke P.
Generation of human red blood cells under normoxic and hypoxic conditions.
Transf Med Hemother 2005. 2005; 32(S1):30-- 38. Jahreskongress der DGTI ; Sep 6-9, 2005; Erfurt, Germany.
[Oral Communication]
I. Dorn, J. Ribbat, S. Boie, H. Kirchner, P. Schlenke.
In vitro erythropoiesis induced from CD34 positive cells.
Exp Hematol . 2005; 33(S1):79--34th Annual Scientific Meeting of the ISEH; Jul 30 - Aug 2, 2005; Glasgow, Scotland.
[Poster]
Hartwig D, Dorn I, Kirchner H, Schlenke P.
Recommendations for optimized Settings of the Amicus Crescendo cell separator for the Collection of CD34+ progenitor cells.
Transf Med Hemoth 2004. 2004; 31(S3):16--37. Jahrestagung der Deutschen Gesellschaft für Transfusionsmedizin und Immunhämatologie; Sept 21-24, 2004; Mannheim, Deutschland. (ISBN: 3-8055-7827-X )
[Poster]
I. Dorn, D. Hartwig, S. Boie, B. Driller, P. Schelnke.
ADAR 1 in human erythropoiesis.
Transf Med Hemother 2004. 2004; 31(S3):16--37. Jahreskongress der DGTI ); Sep 21-23, 2004; Mannheim, Germany.
[Oral Communication]
I. Dorn, D. Hartwig, K. Weber, H. Kirchner, P. Schlenke.
In vitro erythropoiesis induced from CD34 positive cells.
D. Transf Med Hemother 2003;30. 2003; 30(S1):13--36. Jahreskongress der DGTI 2003, Innsbruck. (Vortrag); Sep 16-19, 2003; Innsbruck. (ISBN: 3-8055-7673-0 )
[Oral Communication]
I. Dorn, B. Mascher, P. Schlenke, H. Schimmelpennig, E.F. Stange, M. Seyfarth.
Lamina propria plasma- and B-cells – intracellular detection of immunoglobulins using flow cytometry.
Scand J Immunology. 2001; 54(S1):-11th International congress of Immunology; Jul 22-27, 2001; Stockholm, Sweden.
[Oral Communication]
I. Dorn, B. Mascher, P. Schlenke. H. Schimmelpennig, E.F. Stange., M. Seyfarth.
Lamina propria plasma cells in inflammatory bowel disease. Intracellular detection of immunoglobulins using flow cytometry.
Immunobiology 2000
. 2000; 203: 513--Joint annual meeting of the German and Dutch Societies of Immunology 2000, Düsseldorf.
; Now 29 - Dec 2, 2000; Düsseldorf, Germany.
[Poster]
Dorn I, Mascher B, Schlenke P, Stange EF, Seyfarth M. .
Lamina propria plasma cells – intracellular detection of immunoglobulins using flow cytometry.
Immunology Letters 1999. 1999; 69(1):107--10th International Congress of Mucosal Immunology. ; 1999; Amsterdam , Niederlande.
[Poster]